Luxturna gene therapy
Credit: OHSU News
Two syringes with the Luxturna gene therapy are delivered to the surgical team before the surgery begins. Caspian Soto, 4, is among the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)